EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and Biological Evaluation of 2‐Aminothiazole Derivatives as Novel Checkpoint Kinase 1 (CHK1) Inhibitors

Minjie Deng, Peipei Wang, Xiubing Long, Gaoya Xu, Chang Wang, Jia Li, Yubo Zhou, Tao Liu iD

ChemMedChem · 2023

DOI: 10.1002/cmdc.202200664 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2023. Verfasst von Minjie Deng und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, ZJU-ENS Joint Laboratory of Medicinal Chemistry, Zhejiang University, 310058, Hangzhou, P. R. China. Hauptthemen laut MEDLINE: Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of 2‐aminothiazole derivatives were designed, synthesized on the basis of bioisosterism strategy and evaluated for their CHK1 inhibitory activity. Most of them exhibited potent CHK1 inhibition, and excellent antiproliferative activity against MV‐4‐11 and Z‐138 cell lines. Systematic structure‐activity relationship (SAR) efforts led to the discovery of a promising compound 8 n , which showed potent CHK1 inhibitory activity with IC 50 value of 4.25±0.10 nM, excellent antiproliferative activity against MV‐4‐11 and Z‐138 cells with IC 50 value of 42.10±5.77 nM and 24.16±6.67 nM, respectively, as well as moderate oral exposure (AUC (0−t) =1076.25 h ⋅ ng/mL) in mice. Additionally, treatment of MV‐4‐11 cells with compound 8 n for 2 h led to robust inhibition of CHK1 autophosphorylation on serine 296. Furthermore, kinase selectivity assay revealed that 8 n displayed acceptable selectivity toward 15 kinases. These results demonstrated that compound 8 n may be a promising potential anticancer agent for further development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsAnimalsMiceCell Line, TumorCell ProliferationCheckpoint Kinase 1Drug DesignDrug Screening Assays, AntitumorMolecular StructureProtein Kinase InhibitorsStructure-Activity RelationshipThiazoles

Stichwörter der Autor:innen

2-aminothiazoleCHK1 inhibitorsantiproliferationbiological activityhematologic malignancies

Substanzen

2-aminothiazoleAntineoplastic AgentsCheckpoint Kinase 1Protein Kinase InhibitorsThiazolesChek1 protein, mouse

Autor:innen und Institutionen

  • College of Pharmaceutical Sciences, ZJU-ENS Joint Laboratory of Medicinal Chemistry, Zhejiang University, 310058, Hangzhou, P. R. China.
  • School of Chinese Materia Medica, Nanjing University of Chinese Medicine, 210023, Nanjing, P. R. China.
  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 201203, Shanghai, P. R. China.
  • Wuxi Apptec Co., Ltd., 288 Fute Zhong Road, 200131, Shanghai, P. R. China.
  • Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 528400, Zhongshan, P. R. China.
  • Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, 264117, Yantai, P. R. China.

ORCID-Profile: Tao Liu

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Deng, M., Wang, P., Long, X., Xu, G., Wang, C., Li, J., Zhou, Y., & Liu, T. (2023). Design, Synthesis, and Biological Evaluation of 2‐Aminothiazole Derivatives as Novel Checkpoint Kinase 1 (CHK1) Inhibitors. ChemMedChem. https://doi.org/10.1002/cmdc.202200664

Vancouver

Deng M, Wang P, Long X, Xu G, Wang C, Li J, et al. Design, Synthesis, and Biological Evaluation of 2‐Aminothiazole Derivatives as Novel Checkpoint Kinase 1 (CHK1) Inhibitors. ChemMedChem. 2023. doi:10.1002/cmdc.202200664

BibTeX
@article{Deng2023,
  author = {Deng, Minjie and Wang, Peipei and Long, Xiubing and Xu, Gaoya and Wang, Chang and Li, Jia and Zhou, Yubo and Liu, Tao},
  title = {Design, Synthesis, and Biological Evaluation of 2‐Aminothiazole Derivatives as Novel Checkpoint Kinase 1 (CHK1) Inhibitors},
  journal = {ChemMedChem},
  year = {2023},
  doi = {10.1002/cmdc.202200664}
}
Kostenlos starten →